Photo from Erman Akkus/X
May 23, 2024, 10:36
Erman Akkus: Is patient participation in cancer drug trials associated with longer survival compared with routine care?
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X:
“Is patient participation in cancer drug trials associated with longer survival compared with routine care? .
- No survival benefit
- When only high-quality studies were pooled (HR, 0.9)
- When the sample was adjusted for possible publication bias (HR, 0.94)
- Interpretation of authors: Excluding patients from trials due to geography, nonavailability of trials in their condition, or ineligibility does not deprive them of survival opportunities
- doi:10.1001/jama.2024.6281″
Source: Erman Akkus/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 2, 2024, 10:01
Dec 2, 2024, 09:04
Dec 1, 2024, 22:10